Average Co-Inventor Count = 5.43
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Gilead Sciences, Inc. (54 from 919 patents)
2. Virobay, Inc. (7 from 22 patents)
3. Gilead Pharmasset LLC (4 from 79 patents)
4. Axys Pharmaceuticals, Inc. (4 from 40 patents)
5. Aventis Pharmaceuticals Inc. (3 from 207 patents)
6. Amygdala Neurosciences, Inc. (2 from 4 patents)
7. Schering Aktiengesellschaft (1 from 1,384 patents)
8. University of Houston System (1 from 588 patents)
9. Gilead Scineces, Inc. (1 from 1 patent)
10. Quest Diagnostics Investments, Inc. (479 patents)
11. Carna Biosciences, Inc. (12 patents)
74 patents:
1. 12404262 - Therapeutic compounds for HIV virus infection
2. 12338233 - PD-1/Pd-L1 inhibitors
3. 12269812 - PD-1/PD-L1 inhibitors
4. 11993583 - Therapeutic compounds
5. 11976072 - Diacylglycerol kinase modulating compounds
6. 11932634 - Diacylglycerol kinase modulating compounds
7. 11926628 - Diacylglyercol kinase modulating compounds
8. 11845723 - Diacylglycerol kinase modulating compounds
9. 11753399 - Therapeutic compounds
10. 11702404 - GLP-1R modulating compounds
11. 11555029 - PD-1/PD-L1 inhibitors
12. 11267801 - Therapeutic compounds
13. 11236085 - PD-1/PD-L1 inhibitors
14. RE48711 - Apoptosis signal-regulating kinase inhibitors
15. 10899735 - PD-1/PD-L1 inhibitors